Navigation Links
Benefits of radionuclide therapy for neuroendocrine tumors
Date:9/20/2011

Reston, Va. (September 20, 2011) According to new Dutch research featured in the September issue of The Journal of Nuclear Medicine, a peptide receptor radiolabeled therapy (PRRT), [177Lu-DOTA0,Tyr3]Octreotate (177Lu-octreotate) , is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis. While many neuroendocrine cancers are incurable, they grow relatively slowly, and life expectancy is relatively long, making quality of life an important factor in treatment.

In particular, the study "Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Try3]Octreotate" focused on gastroenteropancreatic or bronchial neuroendocrine tumors. These tumors are relatively rare neoplasms that derive from the neuroendocrine system; they affect approximately 1-2.5 individuals per 100,000. Since they often have unpredictable biological behavior, the time from discovery to final diagnosis of the tumors is frequently delayed.

"In patients with gastroenteropancreatic or bronchial neuroendocrine tumors, median progression-free survival after therapy with 177Lu-octreotate is 40 months. Such a survival is promising only if the years that are gained are free of serious side-effects or symptoms that affect quality of life," said Saima Khan, MD, lead author of the study. "We showed that the years gained after this therapy show an improved quality of life, as judged by the patients themselves, according to a validated questionnaire. Moreover, this type of treatment lacks most of the serious adverse events and symptoms that are typical with chemotherapeutic agents."

For the study, 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors were treated with the radiolabeled pharmaceutical 177Lu-octreotate. Follow-up visits were scheduled at fixed time points: six weeks, three months and six months after
'/>"/>

Contact: Susan Martonik
smartonik@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
2. 1Dental.com Enhances Dental Plan Benefits With New Fee Schedule
3. Freedom Healthnet Affirms Affordable Private Health Insurance Benefits
4. Surgeon General with Microsoft HealthVault Expands Consumer Benefits for the My Family Health Portrait Offering
5. DSM Personalized Nutrition Webinar Explores Benefits of Nutrition for Employee Health
6. Greenway Medical Technologies Advances Patient-Provider Benefits
7. LG Electronics Expands Benefits of Healthcare HDTVs With New Compliance Ratings at HIMSS 2010
8. Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis
9. New study questions benefits of elective removal of ovaries during hysterectomy
10. Health Benefits Direct Announces Extension of Expiration of Rights Offering to March 26, 2010
11. Study evaluates costs and benefits of new chemotherapy drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Dr Murray Grossan was interviewed for an article in ... October 2014 issue of Bottom Line Personal magazine, there will ... treating snoring, and in some cases Obstructive Sleep Apnea. ... adults snore occasionally, and about 25% do it all the ... the back of the throat tend to sag when you ...
(Date:8/21/2014)... 22, 2014 Benefiting from accelerated ... medical expenses, the Chinese orthopedic instrument market demand ... a CAGR of 19.2% during 2009-2013. Trauma products, ... segments of orthopedic instruments in China, of which ... share in 2013. , Being optimistic about bright ...
(Date:8/21/2014)... 2014 Strongly influenced by their ... when there are no consequences, researchers in Georgia ... , This could imply that humans are less ... others, researchers said. Their findings are published in ... sense of unfairness is affected by their self-interest, ...
(Date:8/21/2014)... August 21, 2014 Local agencies in ... larger discounts for specific protection plans, according to released ... consumers to quote life insurance from local agencies using ... local agents that appear inside of the national system ... method of price reviews this year. Adults who enter ...
(Date:8/21/2014)... 22, 2014 The “Proteomics Market ... Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - ... 2018", analyzes and studies the major market drivers, ... and the Rest of the World (RoW) , ... through 415 pages and in-depth TOC on “Proteomics ...
Breaking Medicine News(10 mins):Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 2Health News:Influenced by Self-Interest, Humans Less Concerned About Inequity To Others, Researchers Find 3Health News:Life Insurance from Local Agents Now Priced Nationally Through Complimentary Tool Online 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 2Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 3Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 4Health News:Proteomics Market worth $20,696.4 Million by 2018 - New Research Report by MarketsandMarkets 5
... in births of autistic children have led to a fear ... towards an autistic epidemic. However a recent report, which was ... out that this is not true. The report points out ... autistic epidemic., ,The study had pointed out that recent ...
... size at birth, as a marker of an adverse ... // death from cardiovascular disease, according to the study ... obtained by studying 13830 individuals born between 1924 and ... causes of death between 1971 and 1998 was obtained ...
... Aptivus ( tipranavir ) , has been recently approved ... are to be given in combination with ritonavir for treatment ... for patients with advanced HIV disease, and provides a new ... of Aptivus in combination with ritonavir, has shown to be ...
... to varying degrees of energy loss during aerobic exercises and ... our bodies react to exercise programs is genetic in origin ... level of blood glucose in the body etc. ,According ... Washington University School of Medicine, exercise can help the scientists ...
... India ,German Remedies, a part of the Zydus group, has ... lymphocytic leukemia. Chronic Lymphocytic Leukemia (CLL) is a cancer of ... present has no cure. The disease is unknown in childhood, ... with increasing age. ,Fludarabine has emerged as one ...
... of the smokers reveals that the smokers may differ in ... to smoking. ,Researchers have found that the urge to ... according to the brain responses to the smoking habit. Researchers ... brain images of smokers in a bid to study the ...
Cached Medicine News:
(Date:8/21/2014)... FLORHAM PARK, N.J. , Aug. 21, 2014 ... specialty pharmacy group purchasing organization (GPO), is pleased ... (Aurora) to collaborate on a host of innovative ... will help Aurora deliver enhanced therapy management services ... Therapy Management (OTM) system. Aurora will ...
(Date:8/21/2014)... TORONTO , Aug. 21, 2014 /CNW/ - Bedrocan ... appointed three independent members to its Board of ... care experience of the company, a leading licensed ... . Internationally, Bedrocan has 13 years, experience ... patients in seven countries, including Canada. ...
(Date:8/21/2014)... 21, 2014   Auxilium Pharmaceuticals, Inc. ... company, today announced positive results from a randomized, ... (or CCH) for the treatment of edematous fibrosclerotic ... Phase 2a trial, all three doses of CCH ... an improvement in the appearance of cellulite as ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: